Detalhe da pesquisa
1.
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus.
Clin Infect Dis
; 74(1): 95-104, 2022 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33693561
2.
Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model.
J Neurovirol
; 26(6): 838-845, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32901392
3.
Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers.
Antimicrob Agents Chemother
; 63(9)2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31285228
4.
Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro.
J Neuroinflammation
; 16(1): 182, 2019 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31561750
5.
Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors.
PLoS Pathog
; 13(12): e1006740, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29267399
6.
Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells.
J Am Chem Soc
; 140(7): 2478-2484, 2018 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29406750
7.
Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth.
Angew Chem Int Ed Engl
; 56(50): 16023-16027, 2017 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29076273
8.
Corrigendum: Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth.
Angew Chem Int Ed Engl
; 59(31): 12575, 2020 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32691956
9.
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck.
Cancer
; 120(24): 3940-51, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25103371
10.
Enhanced antiretroviral therapy in rhesus macaques improves RT-SHIV viral decay kinetics.
Antimicrob Agents Chemother
; 58(7): 3927-33, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24777106
11.
Randomized, double-blind, multicenter safety and efficacy study of rifalazil compared with azithromycin for treatment of uncomplicated genital Chlamydia trachomatis infection in women.
Antimicrob Agents Chemother
; 58(7): 4014-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24798277
12.
Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections.
Viruses
; 16(4)2024 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38675992
13.
Cellular pharmacology and potency of HIV-1 nucleoside analogs in primary human macrophages.
Antimicrob Agents Chemother
; 57(3): 1262-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23263005
14.
Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors.
Drug Discov Today Technol
; 9(3): e183-e193, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23554824
15.
Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator.
Viruses
; 13(1)2021 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33467678
16.
Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study.
Metabol Open
; 10: 100090, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33889834
17.
Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study.
J Clin Pharmacol
; 61(12): 1555-1566, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34169526
18.
Lack of pharmacokinetic interaction between amdoxovir and reduced- and standard-dose zidovudine in HIV-1-infected individuals.
Antimicrob Agents Chemother
; 54(3): 1248-55, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20038617
19.
Approaches for the development of antiviral compounds: the case of hepatitis C virus.
Handb Exp Pharmacol
; (189): 25-51, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19048196
20.
Development of an optimized dose for coformulation of zidovudine with drugs that select for the K65R mutation using a population pharmacokinetic and enzyme kinetic simulation model.
Antimicrob Agents Chemother
; 52(12): 4241-50, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18838591